We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Court Favors Cardium In Gene Therapy Patent Dispute

Law360 (May 11, 2006, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has ruled that Arch Development Corp. and Arch’s licensee, Boston Scientific Corp. will not be able to assert patents relating to a...
To view the full article, register now.